Linked Life Data

21029328

Source:http://linkedlifedata.com/resource/pubmed/id/21029328

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-12-14
pubmed:abstractText
The effect of an ?-melanocyte stimulating hormone (?-MSH) analogue (AP214) on experimentally endotoxin-induced systemic inflammatory response syndrome (SIRS) was studied, because ?-MSH in rodent models has shown promise in attenuating inflammatory response markers and associated organ damage in SIRS. SIRS is associated with considerable morbidity and mortality. Consequently, new treatment modalities are still warranted to address the different aspects of the pathophysiological process.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1475-097X
pubmed:author
pubmed:copyrightInfo
© 2010 The Authors. Clinical Physiology and Functional Imaging © 2010 Scandinavian Society of Clinical Physiology and Nuclear Medicine.
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
54-60
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
The ?-MSH analogue AP214 attenuates rise in pulmonary pressure and fall in ejection fraction in lipopolysaccharide-induced systemic inflammatory response syndrome in pigs.
pubmed:affiliation
Department of Clinical Physiology ?The Institute of Clinical Medicine, Aarhus University Hospital, Skejby, Aarhus, Denmark. jenskristensen@dadlnet.dk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't